If the involvement of the piRNA-PIWI axis in the maintenance of the stem cell phenotype is substantiated, the prospect of targeting piRNAs and/or PIWI proteins emerges as a potential strategy to mitigate the resistance of cancer to treatment. This evidence concerns the gene PIWIL1 and cancer.